Assessing Kiniksa Pharmaceuticals (KNSA) Valuation After Recent Share Price Volatility [Yahoo! Finance]
Kiniksa Pharmaceuticals, Ltd. - Class A (KNSA)
Last kiniksa pharmaceuticals, ltd. - class a earnings: 8/12 04:02 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Kiniksa Pharmaceuticals International (KNSA) has drawn investor interest after a period in which the share price increased roughly 1.7% in the past day but declined about 9% over the past week. See our latest analysis for Kiniksa Pharmaceuticals International. That mix of a 1.71% 1 day share price return and a 7 day share price return of 8.96% suggests short term momentum has cooled, even as the year to date share price return of 3.54% and a very large 1 year total shareholder return hint at earlier enthusiasm now being reassessed. If Kiniksa has caught your eye, this can also be a good moment to look across the sector and see what else is moving in healthcare, including 29 healthcare AI stocks as a potential source of new ideas. With Kiniksa posting annual revenue of US$677.564m, net income of US$59.005m and trading at US$43.49, the key question is whether those fundamentals and past returns justify today's price or if the market is already pricing in future growth. Most P
Show less
Read more
Impact Snapshot
Event Time:
KNSA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KNSA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KNSA alerts
High impacting Kiniksa Pharmaceuticals, Ltd. - Class A news events
Weekly update
A roundup of the hottest topics
KNSA
News
- Kiniksa Pharmaceuticals International (KNSA) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Kiniksa Pharmaceuticals, Ltd. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Kiniksa Pharmaceuticals to Present at TD Cowen 46th Annual Health Care ConferenceGlobeNewswire
- Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wells Fargo & Company from $50.00 to $53.00. They now have an "overweight" rating on the stock.MarketBeat
- Kiniksa Pharmaceuticals International (KNSA) had its price target raised by Wedbush from $50.00 to $53.00. They now have an "outperform" rating on the stock.MarketBeat
KNSA
Earnings
- 2/24/26 - Miss
KNSA
Sec Filings
- 3/4/26 - Form 4
- 3/2/26 - Form 144
- 2/24/26 - Form S-8
- KNSA's page on the SEC website